Publications - Lawrence A . Solberg, M.D.

Back to Research Profile

1. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 Jun; 48(6):1106-14. Epub 2008 Feb 25.
   View PubMed
2. Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer 2008 Feb 1; 112(3):447-54.
   View PubMed
3. Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer 2008 Feb 1; 112(3):447-54.
   View PubMed
4. Barosi G, Mesa RA, Thiele J, Cervantes F, Campbell PJ, Verstovsek S, Dupriez B, Levine RL, Passamonti F, Gotlib J, Reilly JT, Vannucchi AM, Hanson CA, Solberg LA, Orazi A, Tefferi A, International Working Group for Myelofibrosis Research and Treatment (IW Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia 2008 Feb; 22(2):437-8 Epub 2007 Aug 30.
   View PubMed
5. Mesa RA, Verstovsek S, Cervantes F, Barosi G, Reilly JT, Dupriez B, Levine R, Le Bousse-Kerdiles MC, Wadleigh M, Campbell PJ, Silver RT, Vannucchi AM, Deeg HJ, Gisslinger H, Thomas D, Odenike O, Solberg LA, Gotlib J, Hexner E, Nimer SD, Kantarjian H, Oraz Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research Leuk Res 2007 Jun; 31(6):737-40. Epub 2007 Jan 08.
   View PubMed
6. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA Jr, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H, International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006 Sep 1; 108(5):1497-503. Epub 2006 May 04.
   View PubMed
7. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NCP, Gilliland DG, Kantarjian H. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006 Sep 1; 108(5):1497-503.
   View PubMed
8. Solberg LA Jr. Biologic aspects of thrombopoietins and the development of therapeutic agents. Current Hematology Reports 2005 Nov; 4(6):423-8.
   View PubMed
9. Litzow MR, Repoussis PD, Schroeder G, Schembri-Wismayer D, Batts KP, Anderson PM, Arndt CAS, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Tefferi A, Noel P, Solberg LA, Letendre L, Hoagland HC. Veno-occlusive disease of the liver after blood and marrow transplantation: Analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator. Leuk Lymphoma 2002 Nov; 43(11):2099-107.
   View PubMed
10. Scolapio JS, Tarrosa VB, Stoner GL, Moreno-Aspitia A, Solberg LA, Atkinson EJ. Audit of nutrition support for hematopoietic stem cell transplantation at a single institution. Mayo Clin Proc 2002 Jul; 77(7):654-9.
    View PubMed
11. Solberg LA. Therapeutic options for essential thrombocythemia and polycythemia vera. Semin Oncol 2002 Jun; 29(3 Suppl 10):10-5.
    View PubMed
12. Hogan MC, Lee A, Solberg LA, Thome SD. Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult. Am J Hematol 2002 May; 70(1):55-9.
    View PubMed
13. Solberg LA Jr. Physiology of myeloproliferation. Semin Hematol 2001 Jan; 38(1 Suppl 2):5-9.
    View PubMed
14. Tefferi A, Solberg LA, Silverstein MN. A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000 Aug 1; 109(2):141-9.
    View PubMed
15. Moreno A, Colon-Otero G, Solberg LA Jr. The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard? Oncologist 2000; 5(3):238-49.
    View PubMed
16. Perez EA, Tiemeier T, Solberg LA. Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT3 regimen and literature review. Support Care Cancer 1999 Nov; 7(6):413-24.
    View PubMed
17. Solberg LA Jr, Tefferi A, Oles KJ, Tarach JS, Petitt RM, Forstrom LA, Silverstein MN. The effects of anagrelide on human megakaryocytopoiesis. Br J Haematol 1997 Oct; 99(1):174-80.
    View PubMed
18. Tefferi A, Elliott MA, Solberg LA Jr, Silverstein MN. New drugs in essential thrombocythemia and polycythemia vera. Blood Rev 1997 Mar; 11(1):1-7.
    View PubMed
19. Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA Jr. Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of action, efficacy, toxicity, and current indications. Semin Thromb Hemost 1997; 23(4):379-83.
    View PubMed
20. Letendre L, Noel P, Tefferi A, Solberg LA Jr, Gastineau DA, Hoagland HC. Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia. Am J Clin Oncol 1995 Oct; 18(5):382-4.
    View PubMed
21. Gertz MA, Pineda AA, Chen MG, Letendre L, Greipp PR, Solberg LA Jr, Witzig TE, Garton JP, Inwards DJ, Litzow MR, Tefferi A, Kyle R, Noel P. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am J Med Sci 1995 Mar;309(3):152-61.
    View PubMed
22. Solberg LA Jr. The cloning of thrombopoietin. Jacksonville Medicine 1994 Oct; 45:465-7.
23. Tefferi A, Colgan JP, Solberg LA Jr. Acute porphyrias: diagnosis and management. Mayo Clin Proc 1994 Oct; 69(10):991-5.
    View PubMed
24. Menke DM, Greipp PR, Colon-Otero G, Solberg LA Jr, Cockerill KJ, Hook CC, Witzig TE. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. Arch Pathol Lab Med 1994 Aug; 118(8):811-4.
    View PubMed
25. Desauvage FJ, Haas PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the C-MPL ligand. Nature 1994 Jun 16; 369:533-538.
    View PubMed
26. Tefferi A, Solberg LA Jr, Ellefson RD. Porphyrias: clinical evaluation and interpretation of laboratory tests. Mayo Clin Proc 1994 Mar; 69(3):289-90.
    View PubMed
27. Tefferi A, Colgan JP, Solberg LA. A concise review in the diagnosis and management of the acute porphyrias. Mayo Clin Proc 1994; 69:991-5.
    View PubMed
28. Goldberg SL, Tefferi A, Rummans TA, Chen MG, Solberg LA, Noel P. Post-irradiation somnolence syndrome in an adult patient following allogeneic bone marrow transplantation. Bone Marrow Transplant 1992 Jun; 9(6):499-501.
    View PubMed
29. Letendre L, Hoagland HC, Moore SB, Chen MG, Gastineau DA, Gertz MA, Habermann TM, Litzow MR, Noel P, Solberg LA Jr, Tefferi A. Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990. Mayo Clin Proc 1992 Feb; 67(2):109-16.
    View PubMed
30. Silverstein MN, Petitt RM, Solberg LA Jr, Schacter LP, Rosenbloom B, Silver RT, et al. Anagrelide: a therapy for thrombocythemic states, experience in 577 patients. Am J Med 1992; 92:69-76.
    View PubMed
31. Noel P, Solberg LA. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit Rev Oncol Hematol 1992; 12(3):193-215.
    View PubMed
32. Kay AC, Solberg LA, Nichols DA, Petitt RM. Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpura. Mayo Clin Proc 1991 Jun; 66(6):602-7.
    View PubMed
33. Solberg LA Jr. A biological and computational model of megakaryocyte development as a stochastic branching process. Int J Cell Cloning 1990 Jul; 8(4):283-90.
    View PubMed
34. Tefferi A, Thibodeau SN, Solberg LA Jr. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990 May 1; 75(9):1770-3.
    View PubMed
35. Brisson-Jeanneau C, Solberg LA Jr, Sultan Y. Presence of functionally active tissue plasminogen activator in human CFU-M derived megakaryocytes in vitro. Fibrinolysis 1990 Apr; 4(2):107-115.
36. Solberg LA, Oles KJ, Kimlinger TK, Tefferi A, Katzmann JA, Li CY. A new murine monoclonal antibody for the diagnosis of erythroleukemia. Am J Clin Pathol 1990 Mar; 93(3):387-90.
    View PubMed
37. Windebank KP, Tefferi A, Smithson WA, Li CY, Solberg LA Jr, Priest JR, Elliott SC, de Alarcon PA, Weinblatt ME, Burgert EO Jr. Acute megakaryocytic leukemia (M7) in children. Mayo Clin Proc 1989 Nov; 64(11):1339-51.
    View PubMed
38. Jenkins RB, Tefferi A, Solberg LA Jr, Dewald GW. Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3. Cancer Genetics & Cytogenetics 1989 Jun; 39(2):167-79.
    View PubMed
39. Tefferi A, Solberg LA Jr, Petitt RM, Willis LG. Adult-onset cyclic bicytopenia: a case report and review of treatment of cyclic hematopoiesis. Am J Hematol 1989 Mar; 30(3):181-5.
    View PubMed
40. Solberg LA Jr, De Alarcon PA. Commentary: stimulators and inhibitors of megakaryocytopoiesis in human plasma. Blood Cells 1989; 15:186-191.
    View PubMed
41. Therneau TM, Solberg LA Jr, Jenkins RB. Modeling megakaryocyte development as a branching process. Comput Math Appl 1989; 18:959-964.
42. Solberg LA Jr. Stimulators and inhibitors of megakaryocytopoiesis in human plasma. Blood Cells 1989; 15(1):186-91.
    View PubMed
43. Diez-Martin JL, Habermann TM, Gastineau DA, Solberg LA Jr, Letendre L. Nonbacterial thrombotic endocarditis in autologous bone marrow transplantation. Am J Med 1988 Nov; 85(5):742-4.
    View PubMed
44. Yamasaki K, Solberg LA Jr, Jamal N, Lockwood G, Tritchler D, Curtis JE, Minden MM, Mann KG, Messner HA. Hemopoietic colony growth-promoting activities in the plasma of bone marrow transplant recipients. J Clin Invest 1988 Jul; 82(1):255-61.
    View PubMed
45. Silverstein MN, Petitt RM, Solberg LA Jr, Fleming JS, Knight RC, Schacter LP. Anagrelide: a new drug for treating thrombocytosis. N Engl J Med 1988 May 19; 318(20):1292-4.
    View PubMed
46. Grant BW, Solberg LA Jr, Nichols WL, Mann KG. Proliferation and maturation of human megakaryocytes in vitro. Ann N Y Acad Sci 1987 Nov; 509:34-40.
    View PubMed
47. Grant BW, Nichols WL, Solberg LA, Yachimiak DJ, Mann KG. Quantitation of human in vitro megakaryocytopoiesis by radioimmunoassay. Blood 1987 May; 69(5):1334-9.
    View PubMed
48. Solberg LA Jr, Tucker RF, Grant BW, Mann KG, Moses HL. Transforming growth factor-beta inhibits colony formation from human megakaryocytic, erythroid and multipotent stem cells. The Inhibitors of Hematopoiesis 1987; 162:111-21.
49. Bowie EJ, Solberg LA Jr, Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 1986 Jul; 78(1):26-30.
    View PubMed
50. Jenkins RB, Nichols WL, Mann KG, Solberg LA Jr. CFU-M-derived human megakaryocytes synthesize glycoproteins IIb and IIIa. Blood 1986 Mar; 67(3):682-8.
    View PubMed
51. Grant BW, Nichols WL, Solberg LA Jr, Yachimiak DJ, Mann KG. A radioimmunoassay useful for quantitating megakaryocyte growth in vitro. Prog Clin Biol Res 1986; 215:117-21.
    View PubMed
52. Messner HA, Jamal N, Yamasaki K, Solberg LA Jr, Jenkins RB. In vitro examination of human megakaryocyte precursors. Prog Clin Biol Res 1986; 215:319-27.
    View PubMed
53. Solberg LA Jr, Jamal N, Messner HA. Characterization of human megakaryocytic colony formation in human plasma. J Cell Physiol 1985 Jul; 124(1):67-74.
    View PubMed
54. Nichols WL, Gastineau DA, Solberg LA Jr, Mann KG. Identification of human megakaryocyte coagulation factor V. Blood 1985 Jun; 65(6):1396-406.
    View PubMed
55. Messner HA, Solberg LA, Jamal N. Human megakaryocytopoiesis in cell culture. Progress in Clinical & Biological Research 1985; 184:215-22.
    View PubMed
56. Tomlinson GC, Solberg LA Jr. Acute tumor lysis syndrome with metastatic medulloblastoma. A case report. Cancer 1984 Apr 15; 53(8):1783-5.
    View PubMed
57. Breckenridge RL Jr, Solberg LA, Pineda AA, Petitt RM, Dharkar DD. Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience. J Clin Apheresis 1982; 1(1):6-13.
    View PubMed
58. Solberg LA Jr, Wick MR, Bruckman JE. Doxorubicin-enhanced skin reaction after whole-body electron-beam irradiation for leukemia cutis. Mayo Clin Proc 1980 Nov; 55(11):711-5.
    View PubMed
59. Hagen GA, Solberg LA Jr. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 1974 Nov; 95(5):1398-410.
    View PubMed
60. Solberg LA Jr, Forte JG. Differential effects of--SH reagents on transport and electrical properties of gastric mucosa. Am J Physiol 1971 May; 220(5):1404-12.
    View PubMed